Johnson & Johnson should reimburse at least $579 million to the Texas Medicaid system for fraudulently promoting its antipsychotic drug Risperdal for uses not approved by U.S. regulators, a state lawyer told jurors. J&J, the world’s largest health care products company, is defending a lawsuit by Texas Attorney General Greg Abbott that claims the company and its Janssen unit overhyped and overcharged the state for the drug after its approval in 1993.
J&J Should Pay Texas $579 Million for Risperdal, Jury Told
Published January 10, 2012 News Leave a CommentTags: Greg Abbott, Janssen Pharmaceuticals, Johnson & Johnson, Medicaid, Risperdal lawsuit, Risperdal side effects
0 Responses to “J&J Should Pay Texas $579 Million for Risperdal, Jury Told”